IMF Videos Search Content For Care Partner (19) Patient (19) Healthcare Professional (6) Healthcare Provider (5) Series - Any - About the IMF (2) ASCO/EHA (163) ASH (230) Ask Dr. Durie (238) Black Swan Research Initiative (7) Community Workshops (33) Emerging Therapies (20) Facebook Live (21) Health Equity (16) IMF History (4) IMWG (13) Inspirational (16) Living Well with Myeloma (34) Myeloma in a Minute (19) Myeloma Made Simple (15) Myeloma University (12) NLB Webcasts (1) Patient & Family Webinar (27) Q&A (19) Recent News and Developments (4) Treatments (4) Trending Searches in Myeloma (1) Topics Clinical Trials (7) Financial Considerations (1) Frontline Therapy (4) Insurance (1) Relapse/Refractory Myeloma (13) Research Updates (4) Symptom Management (5) Myeloma Stage Early Relapse (1–3 Lines of Therapy) (12) High-Risk Myeloma (6) High-risk Smoldering Myeloma (4) Late Relapse (4–6 Lines of Therapy) (13) Newly Diagnosed (Pre-Treatment or First Treatment) (4) Smoldering Myeloma (2) Types of Therapy Immunotherapies (CAR T; BiTE, etc.) (16) Monoclonal antibodies (3) Supportive Care (5) Year Published 2026 (1) 2025 (5) 2024 (4) 2023 (7) 2022 (1) 2021 (1) 2019 (1) Trusted Voices Dr. Joseph Mikhael (13) Sort Newest firstOldest firstA -> ZZ -> ARelevance Understanding ELREXFIO & Bispecific Antibodies for Multiple Myeloma January 16, 2026 Emerging Therapies High-Risk Smoldering Myeloma & New Frontline Treatments: What Patients Need to Know | IMS Part 2 of 2 October 30, 2025 Emerging Therapies IMS Highlights: Frontline Wins, High-Risk Insights, and What’s Next in Myeloma | Part 1 of 2 October 23, 2025 Emerging Therapies Early Relapsed Multiple Myeloma: What’s Changing in 2025 | Research Breakthroughs from ASCO & EHA August 7, 2025 Emerging Therapies Relapsed Multiple Myeloma: What Every Patient Needs to Know July 24, 2025 Emerging Therapies Top 10 Myeloma Breakthroughs from ASCO & EHA: Frontline Therapy, Early & Late Relapse, and CAR T-cell Insights July 17, 2025 Emerging Therapies How Clinical Trials Transform Myeloma Care & Survival: Awareness, Trust & Access with Brian McMahon November 21, 2024 Emerging Therapies 5 Multiple Myeloma Research Highlights: 2024 International Myeloma Society Meeting | For Patients October 17, 2024 Emerging Therapies What is Immunotherapy for Multiple Myeloma? Understanding Its Role in Treatment September 12, 2024 Emerging Therapies FDA Approved New 4-Drug Combo for Newly Diagnosed Myeloma Patients September 5, 2024 Emerging Therapies Bispecific Antibodies: Late Side Effects September 28, 2023 Emerging Therapies Bispecific Antibodies: Early Side Effects September 21, 2023 Emerging Therapies Load More
